Clinical Trial

Transcranial Direct Current Stimulation for Long COVID Brain Fog and Fatigue

Study acronym: NEUROSTIM-LC
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
Long COVID can cause persistent symptoms such as fatigue, cognitive difficulties commonly described as brain fog, reduced exercise tolerance, and impaired quality of life. Transcranial direct current stimulation (tDCS) is a non-invasive brain stimulation technique that may help modulate brain activity in regions involved in cognition, fatigue, and executive function. The NEUROSTIM-LC study will evaluate the feasibility and potential effects of repeated tDCS sessions in adults with long COVID presenting fatigue and/or brain fog. Participants will receive 30 sessions of tDCS applied over the left dorsolateral prefrontal cortex. Assessments will be performed before and after the intervention to evaluate changes in quality of life, fatigue, cognitive function, brain metabolism, physical performance, autonomic function, sleep quality, psychological symptoms, respiratory function, and blood biomarkers.
Protocol Amendment History 1 change
critical Primary endpoint(s) modified 2026-07-23
Trial Details
NCT Number NCT07709234
Lead Sponsor University of Las Palmas de Gran Canaria
Collaborators: Fundación Canaria Instituto de Investigación Sanitaria de Canarias, Canary Islands Health Service
Conditions Long COVID, Post-COVID Conditions, Fatigue, Cognitive Dysfunction
Enrollment 20 participants
Start Date 2026-09-15
Primary Completion 2027-12-22 (estimated)
Study Completion 2028-03-01 (estimated)
Updated on ClinicalTrials.gov 2026-07-22